Do Presbyopia Drops Work?

👁️ #Presbyopia drops! Do they actually work? Dr. Michael DeCourcey breaks it down: ✅ What’s Available? VUITY® (Pilocarpine 1.25%) – FDA-approved since 2021, commercially available, and can be used once or twice daily. QLOSI™ (Pilocarpine 0.4%) – FDA-approved but launching in 2025, preservative-free, single-use vials. 🔬 How Do They Work? These drops shrink the pupil, using the pinhole effect to sharpen near vision—just like the pinhole occluder you see in the clinic! 🤔 Who’s the Best Fit? The Plano Presbyope (mid-40s, doesn’t wear glasses yet, just starting to notice blurry near vision). Part-time readers who want a temporary fix before considering surgery. ⚠️ Side Effects? Brow ache 🤕 Dimmed vision in low light 🌙 Rare risks like retinal tears (so a dilated exam is a must!). 🚀 What’s Next? Beyond #pilocarpine, new drops are being tested (like Brimcol & LNZ100), and some companies are even trying to restore lens elasticity—though that’s a tougher nut to crack! 💬 What do you think? Will drops ever replace reading glasses? 🤓 Financial Disclosures: None References: Orasis Pharmaceuticals. Qlosi (Pilocarpine Hydrochloride Ophthalmic Solution) 0.4% Package Insert. Mar. 2024, Brice, Thomas. "FDA Approves Twice-Daily Dosing Option for Presbyopia Eye Drop Treatment." Ophthalmology Times, 6 Mar. 2024, https://www.ophthalmologytimes.com/view/fda-approves-twice-daily-dosing-option-for-presbyopia-eye-drop-treatment. Accessed 11 Mar. 2025. AbbVie Inc. Vuity (Pilocarpine Hydrochloride Ophthalmic Solution) 1.25% Package Insert. Dec. 2023